Huadong Medicine Co., Ltd (SHE:000963)
China flag China · Delayed Price · Currency is CNY
27.26
-0.40 (-1.45%)
Aug 31, 2026, 3:04 PM CST

Huadong Medicine Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Huadong Medicine stock has a consensus rating of "Buy" and an average price target of ¥41.59. The average 1-year stock price forecast is 52.57% higher than the current stock price, while the lowest is ¥35.00 (+28.39%) and the highest is ¥49.00 (+79.75%).

Price Target: ¥41.59 (+52.57%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥35.00¥41.59¥42.00¥49.00
Change+28.39%+52.57%+54.07%+79.75%

Analyst Ratings

The average analyst rating for Huadong Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy101010976
Buy211111
Hold111111
Sell000000
Strong Sell111111
Total14131312109

Financial Forecast

Revenue This Year
44.83B
from 43.61B
Increased by 2.80%
Revenue Next Year
47.21B
from 44.83B
Increased by 5.30%
EPS This Year
2.24
from 1.89
Increased by 18.47%
EPS Next Year
2.51
from 2.24
Increased by 12.34%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJan 1, 2022Jan 1, 2023Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
34.56B37.71B40.62B41.91B43.61B44.83B
Revenue Growth
2.61%9.12%7.71%3.16%4.07%2.80%
Gross Profit
10.59B12.03B13.16B13.90B14.10B14.65B
Gross Margin
30.65%31.89%32.38%33.17%32.34%32.68%
Operating Income
2.81B3.15B3.59B4.34B4.12B4.45B
Net Income
2.30B2.50B2.84B3.51B3.41B3.61B
EPS
----1.892.24
EPS Growth
-----1.22%18.47%
Forward PE
29.3430.3927.5719.8318.9812.18
Dividend / Share
0.290.290.580.930.930.82
Dividend Growth
26.09%-100.00%60.35%--12.15%
Free Cash Flow
2.10B604.48M1.86B1.25B2.05B3.59B
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High45.6B
Avg44.8B
Low43.8B

Revenue Growth

Revenue Growth202620272028
High
4.6%
Avg
2.8%
Low
0.4%

EPS Forecast

EPS202620272028
High2.24
Avg2.24
Low2.24

EPS Growth

EPS Growth202620272028
High
18.5%
Avg
18.5%
Low
18.5%